Prot# CPG 10101-003: CPG 10101 Combination Therapy for the Treatment of Hepatitis C: A Phase 1B Open Label Randomized Trial of CPG 10101 Alone, with Interferon, Ribavirin, or Interferon and Ribavirin in the Treatment of Relapsed HCV Subjects